Control of Cervicovaginal HPV-16 E7-Expressing Tumors by the Combination of Therapeutic HPV Vaccination and Vascular Disrupting Agents

Antigen-specific immunotherapy and vascular disrupting agents, such as 5,6-dimethylxanthenone-4-acetic acid (DMXAA), have emerged as attractive approaches for the treatment of cancers. In the current study, we tested the combination of DMXAA treatment with therapeutic human papillomavirus type 16 (H...

Full description

Saved in:
Bibliographic Details
Main Authors: Zeng, Qi, Peng, Shiwen, Monie, Archana, Yang, Ming, Pang, Xiaowu, Hung, Chien-Fu, Wu, T.-C.
Format: Artigo
Language:Inglês
Published: Mary Ann Liebert, Inc. 2011
Subjects:
Research Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3135274/
https://ncbi.nlm.nih.gov/pubmed/21128743
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/hum.2010.071
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items